| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 1, 2026 | ±3.3% | -3.0% | over-priced |
| January 30, 2026 | ±2.3% | -1.3% | over-priced |
| November 7, 2025 | ±3.3% | +1.2% | over-priced |
| May 6, 2025 | ±2.9% | -0.4% | over-priced |
| January 31, 2025 | ±2.6% | +0.5% | over-priced |
| November 5, 2024 | ±2.1% | +2.4% | under-priced |
| May 3, 2024 | ±2.4% | +1.0% | over-priced |
| February 6, 2024 | ±3.4% | +0.5% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $7.06 | $5.5B | $904M |
| Q2 FY2026 | $6.60 | $5.2B | $845M |
| Q1 FY2026 | $6.29 | $5.1B | $808M |
| Q4 FY2025 | $7.15 | $5.2B | $924M |
Parker-Hannifin Corporation (PH) reports in 70 days, with the next report estimated for August 22, 2026. Across the last 8 reports, options priced an average ±2.8% earnings move while the stock actually moved 1.3% on average — the market has systematically over-priced PH's earnings risk. Fundamentals into the print: EPS down 4.2% year-over-year, revenue up 10.6%. QuantLogix's live 5-factor engine currently reads PH as a buy at 58/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →